Document is current
Any future updates will be listed below
-
Authors
Borde, Tabea https://orcid.org/0000-0003-3019-5470
Varble, Nicole A.
Kenigsberg, Alexander
Hazen, Lindsey A.
Saccenti, Laetitia
Pinto, Peter A.
Turkbey, Baris
Wood, Bradford J.
-
Funding
Funding for this research was provided by:
National Institutes of Health Clinical Center
- License Information
-
More Information
Article History
Received: 23 April 2025
Accepted: 27 August 2025
First Online: 21 November 2025
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Institutional Ethics Committee under the approval protocol number 12CC0075 - Center for Interventional Oncology, Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, MD 20892, USA.
: Informed consent was obtained from all individual participants included in the study. Patients signed informed consent regarding publishing their data.
: NV is an employee of Philips Healthcare. NIH co-authors had final control over the data analysis and content of the manuscript.Philips manufactures fusion navigation tools for ultrasound (PercuNav and UroNav), some of which were used in this study. NIH and Philips have a patent licensing agreement that pays royalties from Philips to NIH, a portion of which are then shared with BW. NIH (BW) has intellectual property in the field. BW Principal investigator has a cooperative research and development agreement (CRADA) between NIH and Philips and CRADAs with industry partners unrelated to this work; travel support related to CRADAs; royalties from NIH related to Philips licensing agreement; patents planned, issued, or pending. PAP Institutional CRADA with Philips; royalties from NIH related to Philips licensing agreement; NIH-related patents planned, issued, or pending (U.S. patent nos. 8 447 384 and 10 215830). BT has a CRADA with NVIDIA and Philips. The other authors have no conflict of interest to declare.Philips manufactures fusion navigation tools for ultrasound (PercuNav and UroNav), some of which were used in this study. NIH and Philips have a patent licensing agreement that pays royalties from Philips to NIH, a portion of which are then shared with BW. NIH (BW) has intellectual property in the field. BW Principal investigator has a cooperative research and development agreement (CRADA) between NIH and Philips and CRADAs with industry partners unrelated to this work; travel support related to CRADAs; royalties from NIH related to Philips licensing agreement; patents planned, issued, or pending. PAP Institutional CRADA with Philips; royalties from NIH related to Philips licensing agreement; NIH-related patents planned, issued, or pending (U.S. patent nos. 8 447 384 and 10 215830). BT has a CRADA with NVIDIA and Philips. The other authors have no conflict of interest to declare.Unrelated to this work, NIH has Cooperative Research & Development Agreements (BW is Principal Investigator) with the following: Celsion Corp, BTG Biocompatibles/Boston Scientific, Siemens, NVIDIA, XAct Robotics, MediView.
